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Objective: In small case-control studies, obesity was associated with
worse vitamin D status. Our aim was to assess the association of
adiposity (anthropometric measures as well as dual energy x-ray
absorptiometry) with serum 25-hydroxyvitamin D (25-OH-D) and
serum PTH levels in a large population-based study including older
men and women.
Methods: Subjects were participants of the Longitudinal Aging
Study Amsterdam andwere aged 65 yr and older. In 453 participants,
serum 25-OH-D and PTH were determined, and body mass index,
waist circumference, waist to hip ratio, sum of skin folds, and total
body fat percentage by dual energy x-ray absorptiometry were
measured.
Results: After adjustment for potential confounders, higher body
mass index, waist circumference, and sum of skin folds were statis-
tically significantly associated with lower 25-OH-D (standardized 
values were 0.136, 0.137, and 0.140, respectively; all P  0.05)
and with higher PTH (0.166, 0.113, and 0.114, respectively; all P 
0.05). Total body fat percentage was more strongly associated with
25-OH-D and PTH (0.261 and 0.287, respectively; both P  0.001)
compared with anthropometric measures. Total body fat percentage
remained associated with 25-OH-D after adjustment for PTH, and
with PTH after adjustment for 25-OH-D.
Conclusion: Precisely measured total body fat is inversely associ-
atedwith 25-OH-D levels and is positively associatedwithPTH levels.
The associations were weaker if anthropometric measures were used,
indicating a specific role of adipose tissue. Regardless of the possible
underlying mechanisms, it may be relevant to take adiposity into
account when assessing vitamin D requirements. (J Clin Endocri-
nol Metab 90: 4119–4123, 2005)
VITAMIN D IS well known for its essential role in bonemetabolism and calcium homeostasis (1). However, it
has become increasingly clear that the vitamin D endocrine
system has additional physiological functions (2).
Evidence is increasing that the vitamin D endocrine sys-
tem is related to obesity. Obesity has been found to be as-
sociated with lower levels of serum 25-hydroxyvitamin D
(25-OH-D) (3–11) and higher levels of serum PTH (3, 8, 9, 12,
13). Underlying causes that have been suggested are less sun
exposure in obese subjects due to limitedmobility or clothing
habits and a higher storage of vitamin D in adipose tissue (4,
11). However, overweight may also be the consequence of
poor vitamin D status. Vitamin D is an important determi-
nant of serum PTH levels, and increased PTH promotes
calcium influx into the adipocytes. In these cells, intracellular
calcium enhances lipogenesis, and therefore, PTH excess
may promote weight gain (14, 15).
The relation between body fat content and serum25-OH-D
or PTH has usually been investigated in relatively small
(case-control) studies (3–5, 7–9, 11). Furthermore, not many
studies used direct measures of body fatness. The aim of the
present study was to assess the association of adiposity with
serum 25-OH-D and PTH levels in a large population-based
study including older men and women.
Subjects and Methods
Study sample
The Longitudinal Aging Study Amsterdam is an ongoing cohort
study of the predictors and consequences of changes in autonomy and
well-being in an aging population in TheNetherlands. The sampling and
data collection procedures have been described in detail previously (16).
Briefly, a random sample of older men and women (aged 55–85 yr),
stratified by age, sex, urbanization, and expected 5-yr mortality, was
drawn from the population registers of 11 municipalities in areas in the
west, northeast, and south of The Netherlands. In total, 3107 subjects
participated in the baseline examination (1992/1993).
In 1995/1996, a second examination took place; participants were
then aged 65 yr and older. After an interview at home, participants were
invited for a medical interview at one of the research centers, where
blood samples were obtained. Respondents living in the west (n  685)
were also invited for a whole body dual energy x-ray absorptiometry
(DXA) scan, which was obtained for 518 respondents. The study sample
for the present study included subjects in whom a DXA scan was per-
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formed and serum 25-OH-D and PTH levels were available (n  514).
Subjects with missing anthropometric information (n  61) were ex-
cluded. Therefore, our final study sample consisted of 453 subjects who
were predominantly Caucasian (99%). Informed consent was obtained
from all respondents. The study was approved by the medical ethics
committee of the Vrije University Medical Center.
Measurements
Blood samples were obtained and centrifuged in the morning. Sub-
jects were allowed to have tea and toast, but no dairy products. The
serum samples were stored at 70 C. Serum PTH was measured by an
immunoradiometric assay (Incstar Corp., Stillwater, MN), and serum
25-OH-D was determined according to a competitive binding protein
assay (Nichols Diagnostics, San Juan Capistrano, CA). The interassay
coefficients of variation were 12 and 10%, respectively. The analyses
were carried out at the Endocrine Laboratory of the Vrije University
Medical Center.
The assessments of body mass index (BMI; kilograms per meter
squared), waist circumference (centimeters), and waist to hip circum-
ference ratio (WHR) have been described previously (17). The thick-
nesses of skin folds (millimeters) at the triceps, biceps, suprailiac, and
subscapular were measured in triplicate, and the sum of the mean
thickness of each skin fold was used in the analyses.
Total body fat (kilograms) was measured by whole body DXA (soft-
ware version V5.67A, QDR 2000, Hologic, Inc., Waltham, MA). The
system software first determines bone mineral content and soft tissue
compartments. Then soft tissue is further separated into fat and fat-free
soft tissue masses. The total body fat percentage (percentage) was cal-
culated as (total body fat/total body weight)  100.
Because vitamin D status is partly dependent on sunlight exposure,
we adjusted for the season of data collection. Because mild renal im-
pairment could affect PTH and 25-OH-D homeostasis, we also adjusted
for serum creatinine. The level of physical activity (minutes per day)was
estimated by a validated interview-administered questionnaire for older
subjects (18). Smoking status was classified as smoker or nonsmoker
(cigarettes, tobacco, cigar, and pipe), and alcohol use was classified as
light, moderate, excessive, or very excessive, based on the alcohol con-
sumption index of Garretsen (19).
Statistical analyses
All analyseswere performed using SPSS forWindows (version 11.0.1,
SPSS, Inc., Chicago, IL). Multiple linear regression analyses were per-
formed to study the associations between body composition variables
(independent variables) and serum 25-OH-D or PTH levels (dependent
variables). Because the distribution of serum PTHwas skewed, we used
the logarithmic transformation. We adjusted for potential confounders
by adding them to the regressionmodels. Effect modification by sex was
evaluated by stratified analyses and tested by adding product terms of
body composition variables sex to the regression models. To facilitate
direct comparisons of the strengths of the associations, the results of the
regression models are reported as standardized  values. A standard-
ized  of 0.2 indicates that if the independent variable increases by 1 sd,
the dependent variable increases by 0.2 sd.
Results
Table 1 shows the characteristics of the study participants
according to sex-specific quartiles of total body fat percent-
age. Total body fat was inversely associated with serum
25-OH-D and positively with serum PTH levels in both sexes
(all P  0.05). In 8.0% of the men and 14.4% of the women,
the serum 25-OH-D level was less than 10 ng/ml (25 nmol/
liter; deficient status), and 44.7% of the men and 56.1% of the
women had serum 25-OH-D levels below 20 ng/ml (50
nmol/liter; insufficient status). Anthropometric measures
were also inversely related to 25-OH-D, but this crude as-
sociation was only statistically significant for BMI and waist
circumference in women (P  0.05). BMI, waist circumfer- T
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ence, and sum of skin folds were statistically significantly
and positively associated with serum PTH in women only
(all P  0.05).
After adjustment for age, season, sex, and smoking, higher
BMI, waist circumference, and sum of skin folds were sta-
tistically significantly associated with lower 25-OH-D and
higher PTH concentrations (Table 2, model 1). The associa-
tions of DXA total body fat (either in kilograms or as a
percentage)with serum25-OH-D andPTH levelswere stron-
ger than the associations of the anthropometricmeasures and
were statistically significant for both men and women (Table
2 and Fig. 1).
When analyses were performed for men and women sep-
arately, the associations of body composition variables with
serum PTH tended to be stronger in women than in men,
except for WHR. When interaction by sex was tested, it was
not statistically significant for 25-OH-D, and it was only
borderline statistically significant for sum of skin folds and
PTH (P  0.062). However, when comparing associations
between men and women, substantial differences were ob-
served (Table 2).
Additional adjustment of the associations for serum cre-
atinine, alcohol intake, or physical activity level (total activity
or outdoor activities only) did not appreciably change the
associations (data not shown). After adjustment for smoking,
the associations became stronger (change of 10%); there-
fore, we presented the associations after adjustment for
smoking. The Pearson correlation coefficient between serum
25-OH-D and ln-PTH was 0.30. Additional adjustment for
PTH considerably weakened the associations between mea-
sures of body fatness and 25-OH-D, and additional adjust-
ment for 25-OH-D considerably weakened the associations
between measures of body fatness and PTH (Table 2, model
2). Most associations with DXA-measured total body fat,
however, remained statistically significant.
When we distinguished trunk fat from leg fat and added
them simultaneously to the regression models as two sepa-
rate independent variables, leg fat was a strong determinant
of 25-OH-D, whereas trunk fat was not significantly associ-
atedwith 25-OH-D [standardized value,0.161 (P 0.017)
and 0.054 (P  0.341), respectively]. In contrast, trunk fat
was a strong determinant of PTH levels, whereas leg fat was
not significantly associated with PTH [standardized  value,
0.155 (P  0.013) and 0.055 (P  0.457), respectively].
TABLE 2. Associations [standardized  values (sB)] of body composition variables (continuous, independent variable) in relation to 25-
OH-D (continuous, dependent variable) and in relation to PTH, for both sexes combined and for men and women separately
Model 1 Model 2
Both sexes Men Women Both sexes Men Women
sB P sB P sB P sB P sB P sB P
25-OH-D
BMI 0.136 0.001 0.080 0.182 0.181 0.003 0.096 0.020 0.075 0.203 0.093 0.122
WHR 0.051 0.317 0.081 0.176 0.002 0.969 0.037 0.453 0.072 0.214 0.019 0.752
WC 0.137 0.002 0.125 0.036 0.138 0.025 0.109 0.010 0.117 0.045 0.079 0.182
Sum of skin folds 0.140 0.004 0.129 0.033 0.119 0.054 0.111 0.016 0.129 0.029 0.056 0.343
TBF 0.185 0.000 0.152 0.012 0.186 0.002 0.137 0.003 0.130 0.028 0.110 0.063
TBF% 0.261 0.000 0.170 0.004 0.197 0.001 0.194 0.001 0.142 0.016 0.123 0.038
PTH
BMI 0.166 0.000 0.026 0.685 0.298 0.000 0.126 0.005 0.006 0.921 0.235 0.000
WHR 0.055 0.325 0.039 0.543 0.066 0.352 0.039 0.468 0.019 0.764 0.065 0.327
WC 0.113 0.019 0.038 0.553 0.193 0.005 0.071 0.126 0.007 0.911 0.141 0.029
Sum of skin folds 0.114 0.031 0.002 0.972 0.201 0.003 0.071 0.163 0.030 0.653 0.156 0.016
TBF 0.199 0.000 0.108 0.096 0.255 0.000 0.146 0.003 0.072 0.262 0.189 0.003
TBF% 0.287 0.000 0.147 0.021 0.256 0.000 0.214 0.001 0.108 0.088 0.187 0.004
TBF, Total body fat; WC, waist circumference. Model 1, Adjusted for age, season, smoking, and also for sex if men and women were combined.
Model 2, Model 1 additionally adjusted for PTH or 25-OH-D.
FIG. 1. Mean 25-OH-D levels (SE; upper panel) and mean ln-PTH
levels (SE; lower panel) plotted against the mean total body fat
percentage (TBF) within sex-specific quartiles of total body fat per-
centage, adjusted for age, season, and smoking.
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Discussion
This report shows a strong inverse association between
total body fatness and serum 25-OH-D levels and a strong
positive association between body fatness and serum PTH
levels in older men and women, independent of age, sex,
season, study region, and smoking. The associations were
weaker if anthropometric estimates were used compared
with DXA total body fat percentage.
In the 1980s, small case-control studies showed that serum
25-OH-D levels were lower in obese subjects compared with
nonobese individuals (3, 4, 20), and serum PTH levels were
higher (3), which was confirmed in more recent studies (5, 9,
11). In observational studies, similar associations of BMIwith
25-OH-D or PTHwere shown (7, 8, 12, 13), but thesewere not
always statistically significant (6, 10, 21). In our sample we
found statistically significant associations between BMI and
25-OH-D and between BMI and PTH levels. However, the
associations of these hormoneswith total body fat percentage
by DXA were even stronger, which was also found in
youngerwomen (mean age, 47 yr) (10). These results indicate
that it is adiposity, and not simply body weight or BMI, that
is associated with serum 25-OH-D and PTH concentrations.
Previous studies have probably underestimated the associ-
ations by using anthropometric measures.
In reports from the 1970s (22, 23), it was suggested that the
association between serum 25-OH-D and obesity could be
explained by an increased storage of 25-OH-D in adipose
tissue in obese subjects. Rosenstreich et al. (22) supplemented
rats with radiolabeled vitamin D, and adipose tissue was
found to be the major storage site. Mawer et al. (23) found
similar results in human tissues after injection of radioactive
cholecalciferol. In a more recent study by Wortsman et al.
(11), the capacity of the skin to produce vitamin D was not
altered in obesity.However, the increase in serumvitaminD3
after sun exposure was 57% less in obese compared with
nonobese subjects. The increase in serum vitamin D3 after
oral supplementation was similar in obese and nonobese
subjects. This supports the hypothesis of a decreased release
of endogenously produced vitaminD into the circulation due
to more storage in sc fat in obese subjects (11). The fact that
in our study leg fat was more strongly related to 25-OH-D
levels compared with trunk fat supports the idea that en-
dogenously produced vitamin D is particularly stored in the
sc fat depot (11).
Recently, evidence has been accumulating that obesity can
also be the consequence of a low vitamin D status. Increased
PTH levels, of which serum 25-OH-D is an important de-
terminant, promote calcium influx into the adipocytes. In
these cells intracellular calcium enhances lipogenesis; there-
fore, PTH excess may promote weight gain (14, 15). The fact
that PTHwas also associatedwith adiposity after adjustment
for 25-OH-D could suggest that PTH, also independently of
25-OH-D, contributes to the development of adiposity. The
observation that a higher dietary intake of calcium, which is
related to lower PTH levels, is related to lower body weight
(24) and less weight gain (25) also fits the hypothesis of high
PTH levels as a cause of obesity. Subjects with primary hy-
perparathyroidism, who have increased PTH levels, were
also markedly heavier than age-matched controls (26, 27). In
addition, calcium supplementation, which also decreases
PTH levels, resulted in a greater weight loss compared with
placebo treatment (25, 28). These intervention studies sug-
gest a modest, but causal, relation between serum PTH and
weight change. Serum 25-OH-D is an important determinant
of PTH levels, and interventions have shown that supple-
mentationwith-calcidol resulted inmodest, but significant,
weight loss (29, 30). In our study, however, the 25-OH-D level
was also related to adiposity independently of PTH levels.
In conclusion, in a large population-based study, includ-
ing both men and women, we found that total body fat
percentage measured by DXA is strongly associated with
serum 25-OH-D and PTH levels, independently of age, sex,
season, or smoking. The associations were weaker if anthro-
pometric measures were used, indicating a specific role of
adipose tissue. Long-term longitudinal studieswith repeated
measures of vitamin D and PTH should be performed to
explore the direction of effects underlying our observations.
Considering the possible role of vitamin D and PTH in the
development of cancer, muscle weakness, insulin resistance,
diabetes, and cardiovascular disease (31–33), it may be rel-
evant to take adiposity into account when assessing vitamin
D requirements.
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